Meanwhile, TRIM9 overexpression was reported to promotes uterine leiomyoma progression via enhancement of cell proliferation, reduction of cell apoptosis and regulation of cell cycle and nuclear NF-κB expression (Yang et al. 2020). Here, TRIM9 is linked to uterine corpus leiomyoma.